• 한국전자통신학회논문지
• /
• 제6권6호
• /
• pp.965-971
• /
• 2011

우리나라 암 발생빈도 중 간암은 위암에 이어 두 번째로 흔한 암으로서 조기에 발견될 경우는 치료성적이 우수하여 조기 발견이 대단히 중요시된다. 본 시스템은 간암의 조기발견을 위한 생체 정보 예측 시스템으로, 간암으로 확진된 환자 와 간암이외의 대조군의 혈청을 바이오칩에 반응시켜 압타머 단백질 바이오칩 프로파일을 기계학습을 통해 분류하는 시스템이다. 본 논문에서는 총 85샘플로 구성된 간암 확진환자와 310샘플로 구성된 간암이외의 대조군의 혈액시료를 1149의 서로 다른 올리고로 구성된 압타머 단백질 바이오칩에 반응시켜 획득한 데이터를 인공신경망을 통해 분석한 결과 95.38~97.95%의 분류 성능을 보였다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권4호
• /
• pp.1187-1191
• /
• 2012

This study was conducted to determine the use of screening for stomach, liver, colorectal, breast, and cervical cancers, which are included in the Korean National Cancer Screening Programme. In 2011 the National Cancer Centre in Korea conducted a nationwide, population-based, cross-sectional interview survey using multi-stage random sampling. Participants included 4,100 cancer-free men 40 years and over of age and women over 30 years of age. The lifetime screening rates for stomach, liver, colorectal, breast, and cervical cancers were 76.2%, 54.3%, 56.1%, 79.0%, and, 74.8%, respectively. The rates of recommended screening for stomach, liver, colorectal, breast, and cervical cancers were 64.6%, 22.9%, 35.3%, 60.4%, and 62.4%, respectively. More than 70% of all screening was attributed to organised cancer screening programmes. The main reason given for non attendance was 'no symptoms'. A greater effort is needed to increase screening rates, especially for liver and colorectal cancers.

• 한국간담췌외과학회지
• /
• 제26권3호
• /
• pp.229-234
• /
• 2022

When planning pancreaticoduodenectomy for pancreatic head cancer, the prevalence of anatomical variation of the proximal jejunal vein (PJV), the associated short-term surgical outcomes, and the level of PJV convergence to the superior mesenteric vein must be carefully analyzed from both technical and oncological points of view. The prevalence of the first jejunal trunk (FJT) and PJV located ventral to the superior mesenteric artery is 58%-88% and 13%-37%, respectively. Patients with the FJT had a larger amount of intraoperative bleeding and a higher proportion of patients requiring transfusions compared to those without a common trunk. The risk of transfusion was higher in patients with ventral PJV compared to those with dorsal PJV. Although less frequent, sacrificing the FJT can result in fatal venous congestion of the jejunum. Therefore, a well-planned approach for pancreaticoduodenectomy, based on preoperative evaluation of anatomical variation in the PJV, may help reduce intraoperative bleeding and postoperative morbidity. Additionally, the importance of invasion into the PJVs should be revisited in terms of resectability and oncological clearance.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권16호
• /
• pp.6929-6934
• /
• 2015

Background: Real life management of hepatocellular carcinoma occasionally deviates from guidelines for recommended therapy. Aims: To evaluate how frequent this deviation happens in our center and assess its impact on outcome. Materials and Methods: The treatment of 770 patients (87% males, mean age 57.8 years) was analyzed and the effect of deviation on outcome over 36 months was examined. Results: Of Barcelona Clinic liver cancer stages 0 and A patients, 65.8% received resection, ablation, liver transplantation or transarterial chemoembolisation for unresectable tumors more than 5 cm in diameter, and 34.2% received treatment recommended for later stages. Of stage B patients, 62.2% received recommended therapy, 34.3% of patients received supportive therapy or sorafenib and 3.5% received upward treatment stage migration. Among stage C patients, 7.6% received sorafenib, and most (79.2%) were given supportive care. Deviation from recommended therapy occurred in 34.2%, 37.7%, and 92.4% in stages 0-A, B and C. Survival of stage 0-A patients who received downwards treatment stage migration was lower than those who received recommended treatment (p <0.001). Upward treatment stage migration in stages B, C and D did not improve survival compared to those who received recommended treatment. Conclusions: Deviation from recommended therapy had a negative impact on survival in Barcelona Clinic liver cancer stage A patients.

• Molecules and Cells
• /
• 제44권8호
• /
• pp.569-579
• /
• 2021

Cyclase-associated protein 2 (CAP2) has been addressed as a candidate biomarker in various cancer types. Previously, we have shown that CAP2 is expressed during multi-step hepatocarcinogenesis; however, its underlying mechanisms in liver cancer cells are not fully elucidated yet. Here, we demonstrated that endoplasmic reticulum (ER) stress induced CAP2 expression, and which promoted migration and invasion of liver cancer cells. We also found that the ER stress-induced CAP2 expression is mediated through activation of protein kinase C epsilon (PKCε) and the promotor binding of activating transcription factor 2 (ATF2). In addition, we further demonstrated that CAP2 expression promoted epithelial-mesenchymal transition (EMT) through activation of Rac1 and ERK. In conclusion, we suggest that ER stress induces CAP2 expression promoting EMT in liver cancer cells. Our results shed light on the novel functions of CAP2 in the metastatic process of liver cancer cells.

• Gut and Liver
• /
• 제12권6호
• /
• pp.613-614
• /
• 2018

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권6호
• /
• pp.3855-3859
• /
• 2013

Purpose: Liver cancer, one of the most common cancers in China, is reported to feature relatively high morbidity and mortality. Curcumin (Cum) is considered as a drug possessing anti-angiogenic, anti-inflammation and anti-oxidation effect. Previous research has demonstrated antitumor effects in a series of cancers. Materials and Methods: In this study the in vitro cytotoxicity of Cum was measured by MTT assay and pro-apoptotic effects were assessed by DAPI staining and measurement of caspase-3 activity. In vivo anti-hepatoma efficacy of Cum was assessed with HepG2 xenografts. Results: It is found that Cum dose-dependently inhibited cell growth in HepG2 cells with activation of apoptosis. Moreover, Cum delayed the growth of liver cancer in a dose-dependent manner in nude mice. Conclusions: Cum might be a promising phytomedicine in cancer therapy and further efforts are needed to explore this therapeutic strategy.

• 자원ㆍ환경경제연구
• /
• 제17권4호
• /
• pp.845-873
• /
• 2008

이 연구에서는 회피행위의 다목적성(결합생산) 문제를 최소화할 수 있는 암 검진 행위라는 회피행위 자료에 대해 표본선택편의를 극복할 수 있는 모형을 적용하여, 사망위험 감소에 대한 지불의사금액의 도출과 더불어 확률적 인간생명가치(value of statistical life : VSL)를 추정하였다. 간암 사망위험을 감소시키기 위한 비용 및 시간 등과 관련된 자료를 이용하여 건강 및 안전에 대한 가계생산함수모형의 틀에서 사망위험 감소를 위한 한계편익을 추정하였다. 간암 검사를 받을 확률을 높아지도록 하는 변수는 남성인 경우, 연령이 많을수록, 교육받은 기간이 길수록, 유배우자인 경우, 현재 흡연자인 경우, 가구소득이 높을수록, 건강염려 정도가 높을 때인 것으로 나타났다. 간암 검진과 관련된 비용은 조기 검진으로 인하여 감소하는 사망위험의 크기 및 성별, 교육받은 기간, 유배우자 여부, 가구 소득에 의해서도 예상한 대로 유의한 영향을 받았다. 암 검진에 의한 사망위험 감소 크기(risk)의 한계효과는 321,097원이다. 교육년수(edu)의 경우 1년 증가하면 간암 검진비용이 905원, 가구 소득(hinc)이 100만 원 증가하면 간암 검진비용이 1,743원 증가한다. 한편 남성인 경우가 여성에 비해 간암 검진비용으로 12,310원을, 유배우자가 무배우자에 비해 7,969원을 더 부담하고 있다. 암 검진으로 인한 조기사망위험 감소로부터 도출된 확률적 인간생명가치는 평균 사망위험 감소 수준 및 평균 암 검진 비용 수준에서 3억 2,110만 원이다. 또한 암 검진 소요비용과 암 검진 효과에 대한 불확실성을 위해 민감도 분석의 결과에서는 확률적 인간생명가치가 1억 6,055만 원~6억 4,219만 원으로 추정되었다.

• 대한한의학방제학회지
• /
• 제30권3호
• /
• pp.175-182
• /
• 2022

Objective : This study aims to investigate the active ingredients and potential mechanisms of the beneficial herb on human cancers such as the liver by employing network pharmacology. Methods : Ingredients and their target information was obtained from various databases such as TM-MC, TTD, and Drugbank. Related protein for liver cancer was retrieved from the Comparative Toxicogenomics Database and literature. A hypergeometric test and gene set enrichment analysis were conducted to evaluate associations between protein targets of red ginseng (Panax ginseng C. A. Meyer) and liver cancer-related proteins and identify related signaling pathways, respectively. Network proximity was employed to identify active ingredients of red ginseng on liver cancer. Results : A compound-target network of red ginseng was constructed, which consisted of 363 edges between 53 ingredients and 121 protein targets. MAPK signaling pathway, PI3K-Akt signaling pathway, p53 signaling pathway, TGF-beta signaling pathway, and cell cycle pathway was significantly associated with protein targets of red ginseng. Network proximity results indicated that Ginsenoside Rg1, Acetic Acid, Ginsenoside Rh2, 20(R)-Ginsenoside Rg3, Notoginsenoside R1, Ginsenoside Rk1, 2-Methylfuran, Hexanal, Ginsenoside Rd, Ginsenoside Rh1 could be active ingredients of red ginseng against liver cancer. Conclusion : This study suggests that network-based approaches could be useful to explore potential mechanisms and active ingredients of red ginseng for liver cancer.

• Molecules and Cells
• /
• 제47권2호
• /
• pp.100010.1-100010.12
• /
• 2024

Recently, the incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing due to the high prevalence of metabolic conditions, such as obesity and type 2 diabetes mellitus. Steatotic liver is a hotspot for cancer metastasis in MASLD. Altered lipid metabolism, a hallmark of MASLD, remodels the tissue microenvironment, making it conducive to the growth of metastatic liver cancer. Tumors exacerbate the dysregulation of hepatic metabolism by releasing extracellular vesicles and particles into the liver. Altered lipid metabolism influences the proliferation, differentiation, and functions of immune cells, contributing to the formation of an immunosuppressive and metastasis-prone liver microenvironment in MASLD. This review discusses the mechanisms by which the steatotic liver promotes liver metastasis progression, focusing on its role in fostering an immunosuppressive microenvironment in MASLD. Furthermore, this review highlights lipid metabolism manipulation strategies for the therapeutic management of metastatic liver cancer.